{
    "id": 81,
    "premise": "none",
    "hypothesis": "Patient to be considered for second-line treatment",
    "label": "entailment",
    "explanation": "Patient now has progressive disease.\nPatient with TNBC had stable disease after first-line treatment with chemotherapy.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "Patient to be considered for second-line treatment",
        "refined explanation": "Patient now has progressive disease.\nPatient with TNBC had stable disease after first-line treatment with chemotherapy.\nPatients with progressive disease are considered for second-line treatment.",
        "refined iteration": 1,
        "history explanation": [
            "0 iteration: Patient now has progressive disease.\nPatient with TNBC had stable disease after first-line treatment with chemotherapy.",
            "1 iteration: Patient now has progressive disease.\nPatient with TNBC had stable disease after first-line treatment with chemotherapy.\nPatients with progressive disease are considered for second-line treatment."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that a patient now has progressive disease. *)\\n(* Explanation 2 states that a patient with TNBC had stable disease after first-line treatment with chemotherapy. *)\\n(* Although these explanations provide context, they do not directly imply the hypothesis. *)\\n(* However, the hypothesis suggests that a patient with progressive disease may be considered for second-line treatment. *)\\n(* Since the explanations indicate a progression from stable to progressive disease, it is reasonable to consider second-line treatment. *)\\nthen have \"Considered e \u2227 Agent e x \u2227 ForTreatment e\" sledgehammer', 'solving time': 104.60370755195618, 'proof tactics': [], 'code': 'theory clinical_81_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  Disease :: \"entity \u21d2 bool\"\\n  Progressive :: \"entity \u21d2 bool\"\\n  Has :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Now :: \"event \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Stable :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Chemotherapy :: \"entity \u21d2 bool\"\\n  Had :: \"event \u21d2 bool\"\\n  After :: \"event \u21d2 entity \u21d2 bool\"\\n  Considered :: \"event \u21d2 bool\"\\n  ForTreatment :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Patient now has progressive disease. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. Patient x \u2227 Disease y \u2227 Progressive y \u2227 Has e \u2227 Agent e x \u2227 Patient y \u2227 Now e\"\\n\\n(* Explanation 2: Patient with TNBC had stable disease after first-line treatment with chemotherapy. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Patient x \u2227 TNBC x \u2227 Disease y \u2227 Stable y \u2227 Treatment z \u2227 Chemotherapy z \u2227 Had e \u2227 Agent e x \u2227 Patient y \u2227 After e z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient x\"\\n  (* Hypothesis: Patient to be considered for second-line treatment *)\\n  shows \"\u2203x e. Patient x \u2227 Considered e \u2227 Agent e x \u2227 ForTreatment e\"\\nproof -\\n  (* From the premise, we have the known information about the patient. *)\\n  from asm have \"Patient x\" <ATP>\\n  (* Explanation 1 states that a patient now has progressive disease. *)\\n  (* Explanation 2 states that a patient with TNBC had stable disease after first-line treatment with chemotherapy. *)\\n  (* Although these explanations provide context, they do not directly imply the hypothesis. *)\\n  (* However, the hypothesis suggests that a patient with progressive disease may be considered for second-line treatment. *)\\n  (* Since the explanations indicate a progression from stable to progressive disease, it is reasonable to consider second-line treatment. *)\\n  then have \"Considered e \u2227 Agent e x \u2227 ForTreatment e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient now has progressive disease (from Explanatory Sentence 1)\\nB: Patient with TNBC had stable disease after first-line treatment with chemotherapy (from Explanatory Sentence 2)\\n\\nLogical Relations:\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 10.027641534805298, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'verit found a proof...', 'verit: Try this: using explanation_3 by blast (1 ms)', 'vampire found a proof...', 'cvc4 found a proof...', 'e found a proof...', 'zipperposition: Found duplicate proof', 'e: Found duplicate proof', 'cvc4: Found duplicate proof', 'zipperposition found a proof...', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_81_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  Disease :: \"entity \u21d2 bool\"\\n  Progressive :: \"entity \u21d2 bool\"\\n  Stable :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Chemotherapy :: \"entity \u21d2 bool\"\\n  Has :: \"event \u21d2 bool\"\\n  Had :: \"event \u21d2 bool\"\\n  Considered :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  PatientEvent :: \"event \u21d2 entity \u21d2 bool\"\\n  Now :: \"event \u21d2 bool\"\\n  After :: \"event \u21d2 entity \u21d2 bool\"\\n  ForTreatment :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Patient now has progressive disease *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. Patient x \u2227 Disease y \u2227 Progressive y \u2227 Has e \u2227 Agent e x \u2227 PatientEvent e y \u2227 Now e\"\\n\\n(* Explanation 2: Patient with TNBC had stable disease after first-line treatment with chemotherapy *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Patient x \u2227 TNBC x \u2227 Disease y \u2227 Stable y \u2227 Treatment z \u2227 Chemotherapy z \u2227 Had e \u2227 Agent e x \u2227 PatientEvent e y \u2227 After e z\"\\n\\n(* Explanation 3: Patients with progressive disease are considered for second-line treatment *)\\naxiomatization where\\n  explanation_3: \"\u2203x y e. Patient x \u2227 Disease y \u2227 Progressive y \u2227 Considered e \u2227 Agent e x \u2227 PatientEvent e y \u2227 ForTreatment e\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient x\"\\n  (* Hypothesis: Patient to be considered for second-line treatment *)\\n  shows \"\u2203x e. Patient x \u2227 Considered e \u2227 Agent e x \u2227 ForTreatment e\"\\nproof -\\n  (* From the known information, we have Patient x. *)\\n  from asm have \"Patient x\" <ATP>\\n  (* Explanation 1 provides that there exists a patient with a progressive disease. *)\\n  from explanation_1 obtain y e where \"Disease y \u2227 Progressive y \u2227 Has e \u2227 Agent e x \u2227 PatientEvent e y \u2227 Now e\" <ATP>\\n  (* Explanation 3 states that patients with progressive disease are considered for second-line treatment. *)\\n  from explanation_3 obtain e\\' where \"Considered e\\' \u2227 Agent e\\' x \u2227 PatientEvent e\\' y \u2227 ForTreatment e\\'\" <ATP>\\n  (* Therefore, we can conclude that the patient is considered for second-line treatment. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: patient now has progressive disease (from Explanatory Sentence 1)\\nB: patient with TNBC had stable disease after first-line treatment with chemotherapy (from Explanatory Sentence 2)\\nC: patients with progressive disease are considered for second-line treatment (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, C)\\nImplies(patient now has progressive disease, patients with progressive disease are considered for second-line treatment)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}